期刊文献+

在规范化诊治基础上改进和提高泌尿系统肿瘤综合治疗水平 被引量:3

The Trends and Progress in the Comprehensive Treatments of Urological Malignance
原文传递
导出
摘要 泌尿系统肿瘤是严重威胁患者健康和生命的重要疾病,在临床上呈增多趋势,而对早期和晚期泌尿系统肿瘤的外科手术和非手术治疗已取得明显进展。例如,越来越多适合做根治手术的器官局限性前列腺癌被及时确诊,前列腺癌根治手术也不断优化、改进。根治性膀胱全切术的改良和完善,以及积极的围手术期干预,已使更多高龄、高手术风险的浸润性膀胱癌患者获得根治切除的机会。基于肾癌分子发病机制所研发的多种分子靶向药物,对晚期转移性肾癌患者的疗效已明显优于现有的细胞因子治疗,其从基础研究到临床创新的成功,不仅使肾癌以往缺乏有效非手术治疗的困境得到显著改善,也带动了更多有关肾癌发病机制的基础科研。因此,在泌尿系统肿瘤规范化诊疗的基础上,关注和应用这些进展,并开展相应的临床和基础研究,能为患者提供目前最好的综合治疗,达到更好改善患者生存和预后的目的。 Urological malignance include a group of cancers of urinary system,the incidence of urological cancer shows increasing trend,while the increasing progress in both surgical and non-surgical treatments leads to better therapeutic effects to the patients of urological oncology.For example,more and more prostatic cancers are promptly diagnosed in the stage of organ-confined disease which is suitable for curable therapies,and the surgical technique of radical prostatectomy is well established and being optimized to guarantee the outcome of prostate cancer with the decrease of surgical complication.The improvements of radical cystectomy,along with the optimization of peri-operative intervention,are providing more curable opportunity to elderly and high operative risk patients of bladder cancer.The breakthrough of basic research on molecular pathogenesis of renal cell carcinoma,leads to the innovative clinical translation of molecular targeted therapy in the treatment of metastatic renal cancer.The great success of research and development on targeted therapy now are attracting more and more clinical and basic researches which possibly lead to promising novel treatments to urological malignance in the coming future.For the best clinical practice in urological oncology,it is necessary to pay tremendous attention on the advance of both clinical study and laboratory research,which would be the better way to more effectively improve the survival and prognosis of the patients of urological malignance with comprehensive treatments.
作者 李响 李虹
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第1期74-78,0+4,共5页 Journal of Sichuan University(Medical Sciences)
关键词 泌尿系统肿瘤 综合治疗 Urological malignance Comprehensive treatment
  • 相关文献

参考文献31

  • 1谢立平.前列腺癌流行病学.见:那彦群主编.中国泌尿外科疾病诊断治疗指南(2011版).北京:人民卫生出版社,2011:43-44.
  • 2Rafael FC, Bernardo R, Mane] BP, et al . Retropubic, laparoscopic , and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol,2010;24(12):2003-2015.
  • 3Herbert L. A review of surgical techniques for radical prostatectomy. Rev Urol,2005;7(Suppl2) :11-17.
  • 4Walsh PC, Alan WP. Anatomic radical retropubic prostatectomy. In: Wein AJ. Campbell-Walsh Urology, 9th ed.2031-2045.
  • 5Gustavo FC, Christopher RG, Donghui K, et al . Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures. BJU Int , 2010; 105 (12): 1650-1653.
  • 6Vickers AJ, Savage CJ, Hruza M, et al , The surgical learning curve for laparoscopic compared to open radical prostatectomy: a retrospective cohort study. Lancet Oncol , 2009; 10 (5) : 475- 480.
  • 7熊子兵,石明,Kunwar Ashok,陈铌,张朋,曾浩,李响.耻骨后顺行前列腺癌根治术与逆行根治术的围手术期情况和长期并发症比较[J].四川大学学报(医学版),2012,43(1):95-98. 被引量:2
  • 8Gare JL, Litwin MS, Lai J, et al . Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst ,2010, 102(11) :802-811.
  • 9Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology, 2006, 68(1) : 58-64.
  • 10Taylor lIlJA, Kuchel GA. Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat Clin Pract Urol,2009,6(3) :135-144.

二级参考文献107

  • 1孙颖浩.前列腺癌根治术后的几个主要问题[J].临床泌尿外科杂志,2005,20(2):65-67. 被引量:37
  • 2祁延芳,丛振杰,潘英华.肾平滑肌肉瘤的CT表现[J].放射学实践,2005,20(9):801-802. 被引量:12
  • 3回允中.子宫平滑肌肉瘤组织学诊断现状[J].中华病理学杂志,2006,35(12):711-713. 被引量:5
  • 4吴玉厚,吴冰洁,周国利,张永忠,傅崇罗,康新江.干扰素研究进展[J].生物学教学,2007,32(7):2-4. 被引量:20
  • 5马建辉.肾细胞癌诊断治疗指南.见:那彦群,孙光.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2009:1-15.
  • 6Ivan M. Kaelin ]r WG. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev.200l; 11 (1) :27-34.
  • 7Semenza GL. Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992; 12(12) : 5447-5454.
  • 8Maxwell P. HIF-l: an oxygen response system with special relevance to the kidney. J Am Soc Nepro.2003; 14(11) :2712- 2722.
  • 9Hamacher-Brady A. Brady NR. Logue SE. et al., Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ.2007;14(1):146-157.
  • 10Acker T. Plate KH. Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology. Cancer Treat Res. 2004; 117 : 219-248.

共引文献18

同被引文献22

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部